On the other hand, Prof. Luc Montagnier seems to support GVB's core claim, stating in a recent interview that the new variants are the result of mass vaccination:
It is quite likely that new variants are being created by the vaccine (and by the non-vaccine-RNA jab?) yet we still have the immune system (such as T-cells) do we not? Are not all variants typically very close to the original virus, and so we would already have T-cells that recognize the variants and be able to effectively combat it? I don't hear Luc Montagnier saying the variants will be deadly or more dangerous, he is only talking about their creation. So much smoke and mirrors, divide and conquer, splitting hairs and splitting families, created confusion.On the other hand, Prof. Luc Montagnier seems to support GVB's core claim, stating in a recent interview that the new variants are the result of mass vaccination:
Well, well, well! I found an article on this on RAIR in which you can find the link to a longer version of the interview (w/o subtitles):On the other hand, Prof. Luc Montagnier seems to support GVB's core claim, stating in a recent interview that the new variants are the result of mass vaccination:
On the other hand, Prof. Luc Montagnier seems to support GVB's core claim, stating in a recent interview that the new variants are the result of mass vaccination:
Death rate in England is lowest since records began 20 years ago
Although there are localised hotspots in which the Indian variant is spreading, it is not leading to rising case numbers overall, according to King's data, which tends to be a more up-to-date measure of the state of the pandemic than other figures.
Tim Spector, professor of genetic epidemiology at King's College, said the team was monitoring the variant closely, but there was nothing to suggest that the NHS was in danger of being overrun or that the lockdown release would need to be postponed.
"So far, we see only localised outbreaks or hotspots," he said. "Not only in Bedford and Bolton, which we saw a week ago, but our data shows Newport in Wales, Glasgow and neighbouring areas like East Dunbartonshire or Lanarkshire in Scotland, Aberdeen, Leeds and neighbouring authorities like Kirklees and Wakefield too.
[...]
Latest data show Bolton has seen a big increase in vaccination rates in the under-50s, with 29.5 per cent now having a jab compared to 29.3 in England - an increase of 4.5 per cent. Public Health England's weekly surveillance report shows 71.8 per cent of people in England now have antibodies to Covid, either through vaccination or a prior infection.
Death rate in England is lowest since records began 20 years ago
The proportion of people dying in England fell in April to its lowest level since records began, figures from the Office for National Statistics show. Just 851.2 people per 100,000 died last month - the lowest figure since the ONS started...www.sott.net
I'm curious, and I'd appreciate it, if some of our French members could: (1) check if the English translation of the shorter clip is correct (2) inform if Montagnier says anything additional that might be interesting in the longer version (11min, only in French).Well, well, well! I found an article on this on RAIR in which you can find the link to a longer version of the interview (w/o subtitles):
Bombshell: Nobel Prize Winner Reveals - Covid Vaccine is 'Creating Variants' - RAIR
Prof. Luc Montagnier said that epidemiologists know but are "silent" about the phenomenon, known as "Antibody-Dependent Enhancement" (ADE).rairfoundation.com
Concerning the English translation I would say yes, it's quite correct.I'm curious, and I'd appreciate it, if some of our French members could: (1) check if the English translation of the shorter clip is correct (2) inform if Montagnier says anything additional that might be interesting in the longer version (11min, only in French).
I'm thinking of making subtitles to the shorter clip.
Question: You were the first a year ago to claim, that the virus was likely from a lab, but that there was no need to fear it, as nature takes charge of its pathogenic load. My question is, where do the variants come from?
Montaignier: There is no doubt that variants are a result of the vaccine. Especially RNA viruses have a high potential for variation. The RNA double-helix is very stable, and infectious, it is resistant to RNase. RNA is more rigid than DNA, it has less water molecules, it is denser.
The virus is a chimera, part made in a lab, but also has a natural base.
Question: When we have a look at the graphs from WHO, we can see, that from January, since vaccination began, there has been an increase in transmission, and death - especially in younger people - thrombosis etc. What is your view about this massive vaccination campaign, given that there are effective treatments available?
Montaignier: This is an enormous error - a scientific error! It is inacceptable! History will one day analyze this. It is in fact vaccination which has created new variants. If the virus is attacked by antibodies, the it is either death or find a solution. And this can be seen in every country. The curve of vaccination closely follows the curves of deaths. The new variants are resistant to the vaccine. We can also see that people get infected after receiving the vaccine.
Question: How can we possibly vaccinate during a pandemic?
Montaignier: It’s unthinkable! There is silence! But epidemiologists know that. It is antibodies that enhance the infection. It’s called “antibody-dependent enhancement” (ADE). The new variants are created by selection, by the antibodies that are elicited by the vaccines. That is number one.
But number two: Nature has created pathways it doesn’t utilize. Nature has chosen to vary with a concept that is not known to scientists, although it is know to artists: Nature uses harmonic series, especially Fibonacci numbers. The variants more progressively towards Fibonacci numbers in the ratio between Adenin-Uracil vs. Guanin-Cytosin. Why? Because the genetic code degenerates. Because an amino acid can be coded by different nucleotid bases. The code changes, but the product, the protein, remains the same. Pfizer engineers have tweaked the RNA to hold it as long as possible in the organism. For that it needs to be enriched in Guanin-Cytosin, as this is stronger than Adenin-Uracil.So all the variants have Fibonacci numbers, but the vaccines don’t.
Question: Today we heard that the vaccine passport has been approved (in France).
Montaignier: It’s a scandal! And there will be more and more trouble from the vaccine - cancer etc.
Question: The mRNA vaccine is a chimera, correct?
Montaignier: Yes.
Question: We don’t know what will happen in 2-3 years ...
Montaignier: The mRNA will replicate. Maybe it replicates after the vaccine, maybe later. But we cannot prevent double-stranded RNA to be in the cell in a very stable form.
Question: And what will be the consequence?
Montaignier: We don’t know, nobody knows.
Question: They recently found 150 doses of vaccines containing only normal saline.
Montaignier: The engineers of Pfizer in a way did a magnificent job. The RNA is well packaged, well constructed to be translated. And it needs to be translated to be able to produce the spike protein in sufficient quantity to elicit antibody production. And the spike protein favors infection, that’s why you see an increase after vaccination.
Question: What would you do if you were asked to take the vaccine?
Montaignier: I would refuse. That’s what my conscience tells me.
Question: What would you like to tell the 200’000 general practitioners?
Montaignier: Behave like doctors, and not like sheep. The doctors are scared. There is a lot of pressure: If you don’t vaccinate, you are a bad doctor.
Question: Professor Fourtillan is still in imprisoned. Only because he tried to treat people in unorthodox ways.
Montaignier: The first arrest caused quite a stir, but the second one, not a word!To put patches on people’s skins is not a crime!
Question: Global vaccination has led to many deaths - alone in Europe 10’000, directly attributed to the vaccine. And these are official numbers. 10’000 deaths is enormous. And who goes to jail for that?
Montaignier: That’s a very good question. Fourtillan is still imprisoned, but nobody says a word!
Wow, thanks! And thanks also to @Persephone for confirming the translation. The longer version is even more interesting! I hope that someone will do English subs to that one. I would do it myself, based on nicklebleu's transcript, but I'm so lousy at French that I couldn't place the lines with correct time stamps.This is a vague transcript - not verbatim, but a bit shortened.
andEx-Pfizer scientist and high-profile critic Dr Mike Yeadon has published a response to Vanden Bossche's theory about variants and antibodies. Here is the text:
On the other hand, Prof. Luc Montagnier seems to support GVB's core claim, stating in a recent interview that the new variants are the result of mass vaccination:
Summary
- CD4+ T cells help B cells to produce antibodies and help CD8+ T cells to kill virus-infected cells
- One of the dominant cytokines produced by T cells is interferon gamma, a key player in controlling viral infection – see also [41]
- Lymphopenia is a main feature of COVID-19 infection, affecting CD4+ T cells, CD8+ T cells, and B cells, and is more pronounced in severely ill patients
- T cell responses in severely ill patients may be impaired, over-activated, or inappropriate, and further research is required to elucidate this and inform treatment strategies
- There is some evidence of cross-reactivity with seasonal/endemic coronaviruses
- Emerging studies suggest that all or a majority of people with COVID-19 develop a strong and broad T cell response, both CD4 and CD8, and some have a memory phenotype, which bodes well for potential longer-term immunity
- Understanding the roles of different subsets of T cells in protection or pathogenesis is crucial for preventing and treating COVID-19
Thanks nicklebleu for the transcript. I could acces the video only later and what caught my attention was this point :This is a vague transcript - not verbatim, but a bit shortened.
Yeadon is basically not understanding the difference between viral escape from protection-blocking immunity and viral escape from infection-/ transmission-blocking immunity.
His rhetoric about conserved T cell epitopes and long-lived cross-reactive MHC cl I-restricted responses to those, relate to protection against clinical disease but not against infection!
Yeadon doesn’t seem to understand the mechanism of S-directed immune selection, let alone adaptation of variants to conditions of suboptimal, S-directed immune pressure, which become increasingly prevalent upon mass vaccination. I can barely believe that someone who claims to be a skilled expert in immunology doesn’t see the parallel to serial in vitro cell culture passage of a mutable virus in the presence of suboptimal antibody (Ab) concentrations. In case of CoV inoculated on permissive cells, one would incubate the inoculated cell culture in the presence of suboptimal S-specific Abs to place infectious pressure on viral infectiousness. Provided you harvest the viral progeny and use it to repeat this procedure a number of times, you’ll manage to progressively enrich the viral progeny with naturally occurring S variants that have been selected to overcome the immune pressure placed on the S protein and which are, therefore, more infectious in nature. As the selected immune escape variants are so to speak ‘trained’ to reproduce more efficiently, they will now enjoy a competitive advantage in comparison to the wild strain. This is to say that they will now become the dominant variant/ strain! All this occurs of course in the absence of T cells or any kind of active immune response. One simply uses a biological (i.e. an Ab), instead of a chemical or physical agent, to select adequate mutants and enable them to adapt. I don’t get it that Yeadon doesn’t understand that this is highly similar to Sars-CoV-2 being ‘inoculated’ on epithelial cells from humans experiencing suboptimal S-directed immune pressure only (!), as is the case in (a large number of!) people who are in the process of mounting Abs in response to S-based vaccines or who are sitting on short-lived, suboptimal S-specific Abs following asymptomatic infection. In none of these cases the S-directed Abs are accompanied by cytolytic MHC cl I-restricted T cells! Again, when it comes to fighting more infectious variants, Yeadon argues that because of their high degree of sequence homology, variants are ‘irrelevant from an immunological standpoint’. Again, he doesn’t seem to capture that even a single mutation can make a big difference when it enables enhanced infectiousness and is comprised within a variant that is repeatedly exposed to conditions that precisely exert immune pressure on viral infectiousness.
Again, in terms of clinical protection and recovery from disease, CTLs can deal with all of them and I never pretended the opposite. However, more infectious variants will make rise the infection rate in the population, thereby increasing the likelihood that previously asymptomatically infected people get re-infected by a variant within a few weeks (1-6w) after their primary infection. This is at risk of enhancing their susceptibility to the disease as their natural Abs may be sufficiently suppressed by their suboptimal S-specific Abs to no longer be able to eliminate the virus via innate immune cells (most likely NK cells). Yeadon may want to educate himself on natural/ innate Abs and their relevance in fighting a multitude of different pathogens, not just viruses and not only CoV but, for example, also Influenza virus.
Again, in terms of clinical protection and recovery from disease, CTLs can deal with all of them and I never pretended the opposite.
S-directed immune pressure is exerted by vaccinees who have not yet mounted a full-fledged immune response or in previously asymptomatically infected persons whose infection did not result in memory B cell priming.
I think I answered my question above as to what happens to those T cells above.
Looks like GVB is saying asymptomatic people may not be sufficiently primed in terms of their B memory cells.
Question 3 in the FAQ..
According to GVB, asymptomatic infected people cleared the infection through NK cells which are part of the innate immunity. These NK cells have no memory.
Okay, so asymptomatic people will have antigen specific abs which suppress innate immunity i.e. including the NK cells.
So this means next time round the infection will progress until they become clinically ill?
Question: are we seeing real life examples of previously asymptomatically infected people becoming reinfected and testing positive for covid?
As far as I know, people who have been previously infected either asymptomatically or not are not being reinfected again, at least not to anywhere near a high number? So clearly even asymptomatic people have some form of protection that is persisting and I'm assuming holding strong against new emerging variants? Not yet seeing anything yet in the real world to suggest GVB is correct about previously asymptomatic people being in danger from new variants.